Our Pipeline
Our Pipeline
| Category | Project | Type | Co-op Mode | 2023 | 2024 | 2025 | 2026 | 2027 |
| Rx | KX1018 | Glucagon-like Peptide 1 | Co-development | CMC |
Preclinical |
Phase 1 | Phase 2 | |
| KX1012 | Glucagon-like Peptide 1 | Co-development | CMC |
Preclinical |
||||
| KX1017 | Glucagon-like Peptide 1 | Co-development | CMC |
Preclinical |
||||
| KT0002 | Osteoporosis | In-house | CMC |
Preclinical |
||||
| KT0007 | Sleep Aid | In-house | CMC |
Preclinical |
||||
| Vaccine | KX1002 | LNP-Encapsulated mRNA | Co-development | CMC |
Preclinical |
|||
| (mRNA-based Covid-19 vaccine) | ||||||||
| KX1006 | A recombinant adenovirus type-5 vectored | Co-development | CMC |
Preclinical |
||||
| COVID-19 vaccine | ||||||||
| KX1005 | HPV virus-like particle vaccine | Co-development | CMC |
Preclinical |
||||
| KX1010 | Chimpanzee adenovirus vectored | Co-development | CMC |
Preclinical |
||||
| COVID-19 vaccine | ||||||||
© Creway. All Rights Reserved Privacy Policy